Legion Peptides PROFESSIONAL RESEARCH PROTOCOLS LL-37 (5 mg Vial) Dosage Protocol Quickstart Highlights LL-37 (also known as CAP-18) is a 37-amino-acid cationic antimicrobial peptide derived from the C-terminal of human cathelicidin (hCAP18) [1]
These findings may explain the beneficial effects of selenium supplementation in autoimmune thyroid diseases (181, 194), such as reduced levels of anti-thyroid antibodies, improved thyroid structure and metabolism, and ameliorated clinical symptoms (181, 195)
View Canadian testing status & COAs Suggested Research Applications KLOW is frequently explored in laboratory research models involving: Multi-peptide interaction studies across combined signaling pathways Extracellular matrix behavior, collagen-related signaling, and structural support systems Cellular communication and coordination between peptide-regulated processes Tissue response models, including environmental stress and recovery pathways Inflammatory signaling and peptide-mediated modulation in controlled environments Regeneration-associated pathways involving complex peptide stacks Comparative studies with formulations such as GLOW and individual peptide isolates (For laboratory research use only
Discussion Cryptocaryoniasis is currently difficult to control and causes significant issues for marine aquaculture
The capital will be used for expanding its engineering team, to accelerate product development, and to expand into new markets
